Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04089943 · ClinicalTrials.gov registry record · NA
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
A NA study of Peripheral Arterial Disease and Atherosclerosis, sponsored by University of West Florida.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 2
- Study locations
NCT04089943 is a NA study of Peripheral Arterial Disease and Atherosclerosis that has completed, run by University of West Florida. The registered enrollment target is 230 participants, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04089943, a NA study of Peripheral Arterial Disease and Atherosclerosis, has completed, sponsored by University of West Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 2
- Study locations
Study Summary
MicroRNA-210 (miR-210) can be a potential therapeutic target of patients with peripheral artery disease (PAD). Recent evidence suggests the role of miR-210 and oxidative stress in the pathophysiology of PAD and its association with mitochondrial function, oxidative metabolism, walking distances and quality of life. The protocol evaluates the mechanisms which miR-210 regulates oxidative stress and provides evidence of potential therapeutic strategies.
Conditions Studied
Interventions
- OTHER Control group
- PROCEDURE Revascularization operation
Study Locations (2)
Texas
- UT Austing Dell Medical School - Austin
- Baylor Scott and White - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2019-09-15 |
| Est. Completion | 2025-08-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04089943
The ClinicalTrials.gov registry entry for NCT04089943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The listed sponsor is University of West Florida, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Control group is the first listed.
NCT04089943 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04089943 about?
NCT04089943 is a clinical study titled "The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD". MicroRNA-210 (miR-210) can be a potential therapeutic target of patients with peripheral artery disease (PAD). Recent evidence suggests the role of miR-210 and oxidative stress in the pathophysiology of PAD and its association with mitochondrial function, oxidative metabolism, walking distances and ...
What is the current status of trial NCT04089943?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2019-09-15. Estimated completion is 2025-08-25.
What conditions does trial NCT04089943 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Atherosclerosis, Arterial Occlusive Diseases, Vascular Diseases, Peripheral.
What interventions are being tested in trial NCT04089943?
The interventions under investigation include: Control group (OTHER), Revascularization operation (PROCEDURE).
Who is sponsoring clinical trial NCT04089943?
This trial is sponsored by University of West Florida, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04089943 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.